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Abstract
Background: Visceral leishmaniasis is caused by a protozoan parasite, Leishmania donovani and
transmitted by the bite of female sandflies. India is endemic for this disease. On the other hand,
India contributes to the largest number of cases of HIV as well.
Case presentation: We hereby report an unusual case presentation of Visceral leishmaniasis/HIV
co-infection with additional features of Parkinsonism and hyperuriciemia in an Indian male patient
aged about 50 years.
Conclusion: The increasing incidence of HIV/VL co-infection in India is of utmost importance. The
diagnostic and management aspects of these cases are very difficult to handle particularly in an
underdeveloped country like India.
Background
Visceral leishmaniasis (VL) is a disease of prime public
health importance in a developing country like India.
Similarly, Human Immuno-deficiency Virus (HIV) infec-
tion is also assuming a dangerous proportion in this coun-
try. The disease combination of these two is a deadly one.
In Europe it is estimated that approximately 25–70% of
adult cases of VL are HIV co infected [1]. Leishmaniasis is
the third most frequent opportunistic infection in HIV
patients worldwide [2]. The lack of poor reporting system
and diagnostic facilities leads to under reporting of these
diseases.
It is estimated that 350 million people are at risk of VL
with an incidence of 0.5 million and a prevalence of 2.5
million worldwide. About 90% of these cases occur in
Indian sub-continent, Brazil and Sudan. 80% of the
Indian figures occur in Bihar State alone [3]. Since the
advent of HIV/AIDS in 1981 about 25 million people
have died of this disease. In 2007 globally about 2 million
people died of AIDS, 33 million were living with HIV and
about 2.5 million people were newly infected with the
virus. Although the proportion of people living with HIV
in India is lower than previously estimated, the epidemic
continues to affect about 2.5 million people [4]. We
present here an extremely interesting case report of a com-
bination of these diseases along with Parkinsonism, Dia-
betes mellitus and Hyperuricaemia.
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Case presentation
A 50 year old male from a VL endemic village of Bihar pre-
sented to the OPD of this institute in August 2007. He had
fever with weakness and pallor of about 3 months dura-
tion. The fever was associated with chills. He also com-
plained of frequent loose motions in the last 6 months
and had lost about 7 kg of weight. He had dry cough of
one month duration associated with small amount of
haemoptysis and oral ulceration more marked on the
tongue. He also complained of frequent micturition and
pain in the metatarsophalangeal joints of the big toes
bilaterally alongwith some amount of generalized joint
pain.
He was a truck driver by profession and was a frequent vis-
itor to the red light areas of metropolitan cities namely
Mumbai and Kolkata. On close questioning he revealed
having frequent sex with multiple commercial sex work-
ers. He use to take alcohol, toddy and smoked 2–3 ciga-
rettes per day. He had two small children aged 8 years & 6
years (both girls). At the time of presentation he had
bradykinesia with mask facies and characteristic pill roll-
ing tremor more marked on the right side. The arms swing
was also absent on the right side while walking and his
gait was festinant. There were no features of forgetfulness
or dementia, history of falls or any associated autonomic
disturbances. He however had micrographia with monot-
onous speech.
On clinical examination he had a mouth temperature of
102°F (39°C) with a pulse rate of 120/min. His respira-
tion rate was 20/min and his blood pressure was 110/70
mmHg in the left upper limb in supine posture. Chest and
cardio vascular system examination were normal except
for sinus tachycardia. His liver and spleen were palpable 2
cm and 4 cm below the respective coastal margins in the
mid axillary lines. On central nervous system examination
the mask facies, bradykinesia, pill rolling tremor, cog-
wheel rigidity and festinant gait were elicited. Bradyki-
nesia and rigidity were asymmetric. The palmo-mental
and glabellar tap reflexes were positive bilaterally. The
planters were bilaterally flexor. All the above symptoms
were more marked on the right side.
The patient was subjected to various hematological and
biochemical investigations along with splenic aspiration,
chest x-ray postero-anterior view, ultra sonography of
abdomen and computerized tomography (CT scan) of the
brain. He had a hemoglobin level of 6 gm/dl along with a
total count of 4000 cells/mm3. Liver and renal function
tests were normal. His fasting blood sugar was 120 mg/dl
and post prandial level was 160 mg/dl. His serum uric
acid was 7.2 mg/dl. Western Blot for HIV1 was positive.
His CD4 count was 180/μl and CD8 count was 643/μl.
Splenic aspirate for Leishman Donovan bodies was 3+
according to WHO criteria. Ultra sound showed hepat-
osplenomegaly with features of fatty liver. CT scan of the
brain and ECG were normal. ELISA and PCR for tubercu-
losis were negative. MRI and spinal fluid examination
were also done and found normal.
Based of the above findings a diagnosis of HIV1, VL and
Parkinsonism was made. Other associations were diabetes
mellitus and hyperuricaemia. He was put on diabetic diet
and started on Miltefosine 50 mg capsules twice daily for
28 days after meals along with iron and folic acid supple-
ments. He was also administered Allopurinol in the dose
of 100 mg tablets twice daily. He was started on highly
active antiretroviral therapy with two nucleoside reverse
transcriptase inhibitors namely Zidovudine (200 mg)
plus Lamivudine (150 mg) and one non nucleoside
reverse transcriptase inhibitor namely Nevirapine 200 mg
twice daily after food. Parkinson's disease was treated with
Entecapone (100 mg), levodopa (100 mg) and Carbidopa
(25 mg) combination twice daily with Triphenhexidyl (2
mg) twice daily along with Selegiline hydrochloride 5 mg
twice daily. Other D2 receptor agonists like ropinirole or
pramipexole were not added.
After one month of treatment his spleen had regressed,
there was no fever and no LD bodies were seen in the
bone-marrow aspirate. He was continued on antiretrovi-
ral therapy (ART) and Anti-Parkinsonian therapy (enteka-
pone, levodopa, carbidopa, triphenhexidyl and
selegeline) along with allopurinol. His CD4 increased to
300/ml. He was able to walk with considerably less
tremor. He, however, relapsed for visceral leishmaniasis
after 3 months of therapy and was treated with Amphoter-
icin B in the dose of 1 mg/kg body weight for 15 days in
5% dextrose intravenous infusion on alternate days. He
was told to report after one month but was ultimately lost
to follow up. About 6 months later, it was gathered from
his relatives that he had died. VL, itself, is a disease of
poorest of the poor as it mainly affects the low socio-eco-
nomic group and the combination of HIV and Parkinson-
ism makes it more difficult for the people of poor
countries likes India for proper treatment compliance and
regular follow-up visits. It is hoped that possibly due to
this reason the patient could not turn up and eventually
he might have contracted some other AIDS related com-
plications and lost his life. We really feel pity for his poor
family.
Discussion
The treatment and diagnosis of the combination of dis-
eases mentioned above is a very difficult one. As regards
the diagnosis of VL, the demonstration of LD bodies in
the splenic aspirates along with strip test like rK39 and the
relatively new nested PCR can be of great help. Treatment
is very difficult in a setting of HIV combination, as no drugCases Journal 2008, 1:183 http://www.casesjournal.com/content/1/1/183
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along with dosage has been authenticated, there are fre-
quent relapses and drug interactions pose a very difficult
challenge [5].
Sodium Antimony Gluconate (SAG) is developing resist-
ance and unresponsiveness to the said drug has been
reported to be about 43% from Bihar [6]. Pentamidine
particularly because of its side effects has been discarded.
Amphotericin B is a much better option but requires hos-
pitalization and monitoring of serum electrolytes mainly
potassium. Miltefosine or Hexadexylphosphocholine has
completed Phase III and Phase IV and is considered to be
a good drug with an initial cure rate of about 94% [7,8].
However it cannot be given in pregnant women being an
antineoplastic agent. Sitamaquine, a primaquine ana-
logue is in Phase II trial stage. Another drug an aminogly-
coside namely Paromomycin has completed Phase III trial
and has a cure rate of about 95% [9]. Phase IV trials of the
drug are under way.
Various researchers have tried a combination of these
drugs in HIV/VL co-infected cases. This seems to be a good
option as there are frequent relapses However; these com-
binations can lead to an increase in the toxicity [10].
Combinations like Paromomycin with Miltefosine,
Amphotericin B with Miltefosine, SAG with Miltefosine,
SAG with Paromomycin, Liposomal Amphotericin B with
Miltefosine, Amphotericin B with Paromomycin etc are
being tried. ART has to be given along with treatment of
VL. Nevirapine is not to be given with antituberculous
drugs like Rifampicin. Protease inhibitors have various
drug interactions and are very costly. Recently fusion
inhibitors are coming up in the world market but their
main limitation is extremely high cost. Another group of
drugs, the integrase inhibitors are also being tried.
Movement disorders are potential neurological complica-
tions of AIDS. Dopaminergic dysfunction and the predi-
lection of HIV infection to affect subcortical structures are
thought to underlie the development of movement disor-
ders [11]. Extrapyramidal symptoms similar to Parkin-
son's disease have been reported with retonavir/indinavir
and risperidone which have to be used in HIV patients
with psychosis [12]. The treatment of Parkinsonism
requires Levodopa and Carbidopa combination along
with mono amine oxidase B inhibitors like Selegiline and
anti-cholinergics like Triphenhexydil. Newer drugs like
Entecapone (catechol-o-methyl transferase inhibitors)
extend the half life (plasma) and the duration of L-dopa
effect by preventing its breakdown. Dopamine (D2)
receptor agonists like Ropinirole and Pramipexole are also
being tried but are costly and have multiple side effects
like excessive sleepiness, dyskinesia and hypotension etc.
Conclusion
This case report presents new interesting features. Firstly
the combination of HIV and VL is increasing and it is very
difficult to diagnose and treat. Secondly, usually, there are
frequent relapses and combination therapy may be of
great help in this direction. Finally, HIV infection can
present with dyskinesia/Parkinsonism, which may be very
difficult to diagnose, and treat. The standard treatment of
Parkinsonism in HIV patients is usually not beneficial.
Besides other associations like diabetes and hyperuricae-
mia can occur which can be very difficult to treat.
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